(Reuters) – Britain’s medicines regulator on Thursday warned the public about buying fake weight-loss pens claiming to contain Novo Nordisk’s diabetes drug Ozempic or weight-loss drug Saxenda after reports of a few hospitalisations.
“Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK… buying prescription-only medicines online without a prescription poses a direct danger to health,” the Medicines and Healthcare products Regulatory Agency said.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shailesh Kuber)
